Table 2.
Multinomial logistic regression model of NRT adoption typology on baseline organizational characteristics (n = 835).
Baseline Variables | Sustainers vs. Non-Adopters RRR (95% CI) | Discontinuers vs. Non-Adopters RRR (95% CI) | Recent Adopters vs. Non-Adopters RRR (95% CI) | Discontinuers vs. Sustainers RRR (95% CI) | Recent Adopters vs. Sustainers RRR (95% CI) | Recent Adopters vs. Discontinuers RRR (95% CI) |
---|---|---|---|---|---|---|
Privately funded centers (vs. publicly funded centers) | 2.31* (1.17-4.56) | .95 (.47-1.92) | 1.86 (.90-3.86) | .41* (.19-.89) | .81 (.34-1.89) | 1.96 (.81-4.74) |
Therapeutic communities (vs. publicly funded centers) | .59 (.32-1.11) | .90 (.52-1.57) | 1.63 (.87-3.07) | 1.52 (.77-3.01) | 2.75* (1.26-6.02) | 1.81 (.87-3.77) |
Government-owned (vs. not government-owned) | .69 (.32-1.46) | .66 (.33-1.33) | .93 (.45-1.92) | .97 (.41-2.26) | 1.35 (.54-3.35) | 1.40 (.58-3.38) |
For-profit (vs. non-profit) | .98 (.50-1.94) | .67 (.31-1.44) | .44 (.18-1.06) | .69 (.31-1.51) | .45 (.17-1.15) | .65 (.23-1.84) |
Based in a hospital (vs. not based in a hospital) | 6.41*** (3.28-12.53) | 2.22* (1.03-4.79) | 3.50** (1.71-7.14) | .35** (.16-.73) | .55 (.26-1.16) | 1.58 (.67-3.73) |
Inpatient/residential (I/R) and outpatient (vs. I/R-only) | .46** (.26-.81) | .94 (.53-1.64) | .93 (.50-1.73) | 2.06* (1.09-3.89) | 2.04* (1.01-4.14) | .99 (.48-2.03) |
Outpatient-only (vs. I/R-only) | .13*** (.06-.25) | .48* (.25-.92) | .60 (.30-1.19) | 3.78** (1.73-8.25) | 4.68*** (2.02-10.83) | 1.24 (.54-2.86) |
12-step attendance is required (vs. not required) | 1.42 (.85-2.37) | 1.55 (.93-2.58) | .70 (.43-1.14) | 1.09 (.61-1.93) | .49* (.27-.88) | .45* (.24-.83) |
Organizational size (natural log-transformed) | 1.34* (1.04-1.72) | 1.27 (.99-1.64) | 1.40* (1.07-1.83) | .95 (.72-1.26) | 1.05 (.78-1.42) | 1.10 (.80-1.51) |
≥1 physician on staff (vs. no access to physicians) | 2.13* (1.10-4.12) | .87 (.47-1.61) | 1.24 (.66-2.35) | .41* (.20-.85) | .58 (.27-1.28) | 1.43 (.66-3.09) |
≥1 physician on contract (vs. no access to physicians) | 2.20* (1.19-4.07) | 1.15 (.67-1.95) | .95 (.52-1.73) | .52 (.26-1.03) | .43* (.20-.92) | .82 (.40-1.68) |
Used bupropion-SR (vs. not used) | 4.31*** (2.65-7.00) | 6.80*** (4.26-10.87) | 1.33 (.75-2.35) | 1.58 (.96-2.61) | .31*** (.17-.56) | .20*** (.11-.36) |
Taught smoking cessation to patients (vs. not taught) | 5.98*** (3.77-9.48) | 3.32*** (2.14-5.17) | 1.89** (1.18-3.03) | .56* (.33-.93) | .32*** (.18-.55) | .57* (.33-.99) |
Likelihood ratio χ2(39) = 407.83, p<.0001 |
Notes: RRR = relative risk ratio.
p<.05
p<.01
p<.001 (two-tailed tests).